Found: 63
Select item for more details and to access through your institution.
Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment.
- Published in:
- Digital Health, 2023, p. 1, doi. 10.1177/20552076231192754
- By:
- Publication type:
- Article
Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment.
- Published in:
- Digital Health, 2023, v. 9, p. 1, doi. 10.1177/20552076231192754
- By:
- Publication type:
- Article
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antiangiogenic therapies in early-stage breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Antiangiogenic Therapies in Early-Stage Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, p. E23, doi. 10.3816/CBC.2010.s.004
- By:
- Publication type:
- Article
Treatment of HER2-Positive Metastatic Breast Cancer Following Initial Progression.
- Published in:
- Clinical Breast Cancer, 2009, v. 9, p. S50, doi. 10.3816/CBC.2009.s.005
- By:
- Publication type:
- Article
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.707836
- By:
- Publication type:
- Article
Optimizing the Use of Neoadjuvant Endocrine Therapy.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 7, p. 33, doi. 10.1007/s11912-015-0455-z
- By:
- Publication type:
- Article
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 10, p. 5207, doi. 10.3390/ijms22105207
- By:
- Publication type:
- Article
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5490, doi. 10.1172/JCI72573
- By:
- Publication type:
- Article
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
- Published in:
- Cancer & Metastasis Reviews, 2016, v. 35, n. 4, p. 515, doi. 10.1007/s10555-016-9637-x
- By:
- Publication type:
- Article
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 2, p. 275, doi. 10.1007/s10549-024-07417-4
- By:
- Publication type:
- Article
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 319, doi. 10.1007/s10549-022-06797-9
- By:
- Publication type:
- Article
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 2, p. 127, doi. 10.1007/s10549-022-06602-7
- By:
- Publication type:
- Article
Impact of molecular subtype and race on HR+, HER2− breast cancer survival.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 845, doi. 10.1007/s10549-021-06342-0
- By:
- Publication type:
- Article
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 357, doi. 10.1007/s10549-020-05846-5
- By:
- Publication type:
- Article
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings.
- Published in:
- Magnetic Resonance in Medicine, 2014, v. 71, n. 4, p. 1592, doi. 10.1002/mrm.24782
- By:
- Publication type:
- Article
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.
- Published in:
- Scientific Reports, 2017, p. 45828, doi. 10.1038/srep45828
- By:
- Publication type:
- Article
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1685, doi. 10.1007/s40265-020-01394-w
- By:
- Publication type:
- Article
Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035198
- By:
- Publication type:
- Article
Motion correction in diffusion-weighted MRI of the breast at 3T.
- Published in:
- Journal of Magnetic Resonance Imaging, 2011, v. 33, n. 5, p. 1063, doi. 10.1002/jmri.22562
- By:
- Publication type:
- Article
Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.
- Published in:
- Journal of Magnetic Resonance Imaging, 2009, v. 30, n. 1, p. 121, doi. 10.1002/jmri.21812
- By:
- Publication type:
- Article
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab066
- By:
- Publication type:
- Article
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00275-z
- By:
- Publication type:
- Article
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0126-6
- By:
- Publication type:
- Article
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 8, p. 511
- By:
- Publication type:
- Article
Low PTEN levels and <italic>PIK3CA</italic> mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 731, doi. 10.1007/s10549-017-4533-9
- By:
- Publication type:
- Article
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 164, n. 2, p. 371, doi. 10.1007/s10549-017-4265-x
- By:
- Publication type:
- Article
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 149, n. 1, p. 151, doi. 10.1007/s10549-014-3248-4
- By:
- Publication type:
- Article
Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 389, doi. 10.1007/s10549-014-2945-3
- By:
- Publication type:
- Article
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
- Published in:
- 2011
- By:
- Publication type:
- Report
Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 139, doi. 10.1177/1758834012440834
- By:
- Publication type:
- Article
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231711
- By:
- Publication type:
- Article
Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?
- Published in:
- Ecancermedicalscience, 2014, v. 8, n. 413-446, p. 1, doi. 10.3332/ecancer.2014.446
- By:
- Publication type:
- Article
Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2016, v. 7, p. 57
- By:
- Publication type:
- Article
Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 57
- By:
- Publication type:
- Article
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aai7993
- By:
- Publication type:
- Article
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e835, doi. 10.1093/cid/ciaa1571
- By:
- Publication type:
- Article
Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms.
- Published in:
- Medical Physics, 2010, v. 37, n. 6, p. 2541, doi. 10.1118/1.3414035
- By:
- Publication type:
- Article
Radiotherapy after breast‐conserving surgery for elderly patients with early‐stage breast cancer: A national registry‐based study.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 4, p. 857, doi. 10.1002/ijc.33265
- By:
- Publication type:
- Article
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 20, p. 1963, doi. 10.1001/jama.2022.6147
- By:
- Publication type:
- Article
At the Bedside: Profiling and treating patients with CXCR4‐expressing cancers.
- Published in:
- Journal of Leukocyte Biology, 2021, v. 109, n. 5, p. 953, doi. 10.1002/JLB.5BT1219-714R
- By:
- Publication type:
- Article
New Directions in Improving Response to Endocrine Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2016, v. 14, n. 2, p. 87
- By:
- Publication type:
- Article
Platinum Agents in the Treatment of Early-Stage Triple-Negative Breast Cancer: Is It Time to Change Practice?
- Published in:
- Clinical Advances in Hematology & Oncology, 2014, v. 12, n. 10, p. 654
- By:
- Publication type:
- Article
Role of mTOR Inhibition in Preventing Resistance and Restoring Sensitivity to Hormone-Targeted and HER2-Targeted Therapies in Breast Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2013, v. 11, n. 4, p. 217
- By:
- Publication type:
- Article
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
- Published in:
- 2018
- By:
- Publication type:
- journal article